United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for INTENSITY THERAPEUTICS, INC.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -156.9% | -273.14% | 157.71% | 61.21% | 37.99% | 27.59% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -122.92% | -129.69% | -194.37% | -194.42% | -194.55% | -195.05% |
| Total Assets | $14,101.00K | $7,044.28K | $7,044.28K | $7,044.28K | $7,044.28K | $7,044.28K |
| Sector average | $3,280,499.23K | $3,298,345.31K | $3,676,894.01K | |||
| Net Income | -$11,606.00K | -$13,711.92K | -$13,691.72K | -$13,695.31K | -$13,704.80K | -$13,740.07K |
| $4,262,561.28K |
| $4,994,412.92K |
| $5,761,557.24K |